La Fleur & Godfrey LLC Abb Vie Inc. Transaction History

La Fleur & Godfrey LLC

$723 Million
Q3 2024

A detailed history of La Fleur & Godfrey LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, La Fleur & Godfrey LLC holds 76,288 shares of ABBV stock, worth $13.8 Million. This represents 2.08% of its overall portfolio holdings.

Number of Shares

76,288

Previous 78,093 2.31%

Holding current value

$13.8 Million

Previous $13.4 Million 12.48%

% of portfolio

2.08%

Previous 1.97%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$163.84 - $199.33 $295,731 - $359,790	-1,805 Reduced 2.31%	76,288 $15.1 Million
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $194,880 - $227,576	-1,259 Reduced 1.59%	78,093 $13.4 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $1.56 Million - $1.77 Million	-9,731 Reduced 10.92%	79,352 $14.4 Million
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $155,900 - $175,581	1,133 Added 1.29%	89,083 $13.8 Million
Q3 2023 Oct 18, 2023	BUY	$133.59 - $154.65 $16,164 - $18,712	121 Added 0.14%	87,950 $13.1 Million
Q2 2023 Jul 20, 2023	BUY	$132.51 - $164.9 $107,465 - $133,733	811 Added 0.93%	87,829 $11.8 Million
Q1 2023 Apr 18, 2023	SELL	$144.61 - $166.54 $271,722 - $312,928	-1,879 Reduced 2.11%	87,018 $13.9 Million
Q4 2022 Jan 12, 2023	SELL	$138.31 - $165.87 $361,542 - $433,584	-2,614 Reduced 2.86%	88,897 $0
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $1.01 Million - $1.16 Million	-7,513 Reduced 7.59%	91,511 $12.3 Million
Q2 2022 Jul 26, 2022	SELL	$137.62 - $174.96 $3.12 Million - $3.97 Million	-22,693 Reduced 18.64%	99,024 $15.2 Million
Q1 2022 May 03, 2022	SELL	$131.98 - $163.75 $794,123 - $985,283	-6,017 Reduced 4.71%	121,717 $19.7 Million
Q4 2021 Jan 26, 2022	SELL	$107.43 - $135.93 $249,667 - $315,901	-2,324 Reduced 1.79%	127,734 $17.3 Million
Q3 2021 Nov 01, 2021	BUY	$106.4 - $120.78 $1.37 Million - $1.55 Million	12,836 Added 10.95%	130,058 $14 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $352,243 - $392,419	3,348 Added 2.94%	117,222 $13.2 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $526,640 - $579,767	5,148 Added 4.73%	113,874 $12.3 Million
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $507,650 - $685,381	6,307 Added 6.16%	108,726 $11.7 Million
Q3 2020 Nov 04, 2020	SELL	$85.91 - $100.83 $101,373 - $118,979	-1,180 Reduced 1.14%	102,419 $8.97 Million
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $223,705 - $299,350	-3,049 Reduced 2.86%	103,599 $10.2 Million
Q1 2020 May 04, 2020	SELL	$64.5 - $97.79 $48,052 - $72,853	-745 Reduced 0.69%	106,648 $8.13 Million
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $87,637 - $109,653	-1,215 Reduced 1.12%	107,393 $9.51 Million
Q3 2019 Oct 29, 2019	BUY	$62.98 - $75.72 $46,605 - $56,032	740 Added 0.69%	108,608 $8.22 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $111,361 - $142,346	-1,695 Reduced 1.55%	107,868 $7.84 Million
Q1 2019 Apr 17, 2019	SELL	$77.14 - $90.79 $183,593 - $216,080	-2,380 Reduced 2.13%	109,563 $8.83 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $81,742 - $100,810	1,050 Added 0.95%	111,943 $10.3 Million
Q3 2018 Dec 13, 2018	BUY	$88.91 - $98.84 $464,110 - $515,944	5,220 Added 4.94%	110,893 $10.5 Million
Q2 2018 Dec 13, 2018	SELL	$89.78 - $106.23 $218,883 - $258,988	-2,438 Reduced 2.26%	105,673 $9.79 Million
Q1 2018 Dec 13, 2018	BUY	$92.01 - $123.21 $64,591 - $86,493	702 Added 0.65%	108,111 $10.2 Million
Q4 2017 Jan 22, 2018	SELL	$89.56 - $98.21 $233,751 - $256,328	-2,610 Reduced 2.37%	107,409 $10.4 Million
Q3 2017 Oct 26, 2017	BUY	$69.85 - $89.22 $7.68 Million - $9.82 Million	110,019	110,019 $9.78 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $321B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of La Fleur & Godfrey LLC, based on Form 13F filings with the SEC.

News

Stay updated on La Fleur & Godfrey LLC with notifications on news.

Account

La Fleur & Godfrey LLC Abb Vie Inc. Transaction History